Werum IT Solutions and Blood Centers of America prepare for CGT

Article

Werum offers a digital supply-chain solution for managing cellular and genetic therapies

Werum IT Solutions, providers of manufacturing execution systems (MES) and related IT, has a strategic partnership with Blood Centers of America (BCA), a network of independent blood centers that represent nearly 40% of the North American blood supply. The partnership will cover both autologous and allogenic CGTs—the former requiring pickup and delivery of the patient’s own cells; the latter requiring closely managed collection of cellular materials. Supply chain management in CGTs is an evolving field; practitioners in the subject speak of a “chain of compliance” from and to patients, almost always involving close temperature control of cells, and frequently requiring cryogenic preservation.

Werum is a well-recognized player in life sciences MES; its flagship solution, PAS-X, allows for creation and management of electronic batch records. Dr. Andreas Fischer, sr. head of Werum’s SafeCell business unit, says that an end-to-end solution covering both manufacturing and logistics will be developed. Charles Mooney, VP Bio-Development & Quality Management at the Oklahoma Blood Institute and BCA Cell Therapy Committee Chair, adds that “To efficiently manage cell and gene therapies the market needs a comprehensive ‘vein-to-vein’ IT solution that we will create together.”

Newsletter

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Recent Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.